BT, I think this is just another instance of market...

BT,
I think this is just another instance of market manipulation. A trade of just $43 has wiped >35% off the market cap of Nu Sep Holdings Ltd.
Have you had a look at the new PrIME Biologics website <http://primebiologics.com/> ?
I think it went live after the official opening of the new blood plasma fractionation facility in Singapore last Wednesday.
Unfortunately our own NSP website is well out of date.  I think I will be quite happy to wait for the AGM and I look forward to Alison Coutts has to say.
I note in the Annual Financial Report released to market on 1st October 2014 at Page 4 of the Directors' Report it is stated:

"Whilst NuSep considers that the investment has the potential to yield great value to NuSep shareholders in time, its value for present purposes has been calculated on a cost basis which is not a fair value valuation. Internal company analysis has indicated a current valuation to NuSep many fold greater than the SGD$27 million pre-money value of PrIME paid by the series A investors, but given that the range of reasonable fair value estimates is significant and the probabilities of the various estimates cannot be reasonably assessed at this stage, NuSep is precluded from measuring the investment at fair value."

Further at page 5 it is noted that:

"During 2014 SpermSep activities were reinvigorated, building on the work that was done in prior years. NuSep, in collaboration with the University of Newcastle, has shown that the technology provides a simple, quick, cost effective and reliable method of selecting the most viable sperm cells and, unlike current practices of sperm separation for IVF, does not contribute to DNA-damaged sperm."

Finally, the Directors conclude:

"This financial performance reflects the largest change in the company’s history from spinning out the PrIME business. It is pleasing that expenses are now running at a far reduced rate, largely due to separating this business from NuSep and that this expense reduction will also translate even more positively to the next year’s results. However the accounting treatment for valuing PrIME, writing down the value of these assets and writing off expenses for developing that business has had a severe effect on NuSep’s accounts this year. More discussion about this is provided in the commentary in the PrIME section...........As this business meets its performance milestones, NuSep hopes it will be permitted to attribute substantially greater value to this investment in its future financial accounts."

BT I wonder whether it isn't someone who got out wanting to "scare the horses" to allow themselves to get back in cheaply.  Certainly if substantial stock is available below 7 cents I will be a buyer!

DYOR good luck.
Kind regards,